SGRY logo

Surgery Partners, Inc. (SGRY)

Profile

Full Name

Surgery Partners, Inc.

Ticker

NASDAQ: SGRY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

September 30, 2015

Indexes

Not included

Website

http://www.surgerypartners.com

Employees

15000

Key Details

Price

$21.26(+1.19%)

Market cap

$2.72B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.11B(+13.52% YoY)

Annual EPS

-$1.33(-1377.78% YoY)

PE ratio

-

Next earnings date

Aug 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $21.26
    SGRY price is $21.26

    30-Day Relative Volume

    0.54
    SGRY 30-day relative volume is 0.54

    Price Performance

    Price Most recent change

    +1.19%
    SGRY price was up +1.19% on Jul 25, 2025

    Price YTD change

    +0.43%
    SGRY price is up +0.43% since January 1st

    Price 1-year change

    -30.86%
    SGRY price is down -30.86% year-on-year

    Price 3-year change

    -43.71%
    SGRY price is down -43.71% over the past 3 years

    Price Range

    Price All-time high

    $69.58
    SGRY price is currently -69.45% below its historical high of $69.58

    Price 3-year low

    $18.87
    SGRY price is currently +12.67% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $2.72B
    SGRY market capitalization is $2.72 billion

    Market cap 3-year change

    -19.79%
    SGRY market capitalization is down -19.79% over the past 3 years

    Market cap All-time high

    $5.69B
    SGRY market capitalization is currently -52.12% below its historical high of $5.69 billion

    Market cap sector rank

    85%
    SGRY market capitalization is higher than 85% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.82%
    SGRY shares outstanding is up +0.82% year-on-year

    Shares Outstanding 3-Year Change

    +42.5%
    SGRY shares outstanding is up +42.5% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.90
    SGRY beta is 0.90

    200-day SMA

    $23.75
    SGRY price is currently -10.47% below its 200-day simple moving average

    50-day SMA

    $22.39
    SGRY price is currently -5.04% below its 50-day simple moving average

    RSI

    41.99
    SGRY 14-day relative strength index is 41.99

    Volume

    0.54
    SGRY 30-day relative volume is 0.54

    ATR

    $0.66
    SGRY average true range is $0.66

    10-day Historical Volatility

    40.72%
    SGRY 10-day historical volatility is 40.72%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $3.11B
    SGRY annual revenue is $3.11 billion

    Revenue Analysts estimate

    $3.38B
    SGRY annual revenue is currently -7.74% lower than the consensus analysts' forecast

    Revenue 1-year change

    +13.52%
    SGRY annual revenue is up +13.52% year-on-year

    Revenue Sector rank

    88.91%
    SGRY annual revenue is higher than 88.91% of companies in Healthcare sector

    EPS

    EPS

    -$1.33
    SGRY annual earnings per share is -$1.33

    EPS Analysts estimate

    $0.85
    SGRY annual earnings per share is currently -255.87% lower than the consensus analysts' forecast

    EPS 1-year change

    -1377.78%
    SGRY annual earnings per share is down -1377.78% year-on-year

    EPS Sector rank

    48.3%
    SGRY annual earnings per share is higher than 48.3% of companies in Healthcare sector

    Profit

    Gross profit

    $745.60M
    SGRY annual gross profit is $745.60 million

    Gross margin

    23.94%
    SGRY annual gross profit margin is 23.94%

    Operating profit

    $454.30M
    SGRY annual operating income is $454.30 million

    Operating margin

    14.59%
    SGRY annual operating profit margin is 14.59%

    Net income

    -$168.10M
    SGRY annual net profit is -$168.10 million

    Net margin

    -5.40%
    SGRY annual net profit margin is -5.40%

    Expenses

    Total expenses

    $2.66B
    SGRY annual total expenses is $2.66 billion

    Operating expenses

    $291.30M
    SGRY annual total operating expenses is $291.30 million

    Cost of goods sold

    $2.37B
    SGRY annual cost of goods sold is $2.37 billion

    Selling, general & administrative expenses

    $138.70M
    SGRY annual SGA is $138.70 million

    Depreciation and amortization

    $152.60M
    SGRY annual depreciation & amortization is $152.60 million

    Interest expense

    $201.70M
    SGRY annual interest expense is $201.70 million

    Income tax

    $134.60M
    SGRY annual income tax is $134.60 million

    EBIT & EBITDA

    EBIT

    $348.80M
    SGRY annual earnings before interest & taxes is $348.80 million

    EBITDA

    $501.40M
    SGRY annual EBITDA is $501.40 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $7.89B
    SGRY annual total assets is $7.89 billion

    Non current assets

    $6.77B
    SGRY annual long term assets is $6.77 billion

    Current assets

    $1.12B
    SGRY annual total current assets is $1.12 billion

    Cash and cash equivalents

    $269.50M
    SGRY annual cash & cash equivalents is $269.50 million

    Accounts receivable

    $579.10M
    SGRY annual accounts receivable is $579.10 million

    Inventory

    $88.40M
    SGRY annual inventory is $88.40 million

    Liabilities

    Total liabilities

    $4.25B
    SGRY annual total liabilities is $4.25 billion

    Long term liabilities

    $3.63B
    SGRY annual total long term liabilities is $3.63 billion

    Current liabilities

    $624.40M
    SGRY annual total current liabilities is $624.40 million

    Accounts payable

    $208.70M
    SGRY annual accounts payable is $208.70 million

    Debt

    Total debt

    $3.70B
    SGRY annual total debt is $3.70 billion

    Total debt 1-year change

    +20.96%
    SGRY annual total debt is up +20.96% year-on-year

    Long term debt

    $3.56B
    SGRY annual long term debt is $3.56 billion

    Short term debt

    $142.40M
    SGRY annual short term debt is $142.40 million

    Equity & Capital

    Shareholders equity

    $1.79B
    SGRY annual stockholders equity is $1.79 billion

    Book value

    $1.79B
    SGRY annual book value is $1.79 billion

    Retained earnings

    -$737.30M
    SGRY annual retained earnings is -$737.30 million

    Working capital

    $495.00M
    SGRY annual working capital is $495.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $300.10M
    SGRY annual cash flow from operations is $300.10 million

    Cash from operations 1-year change

    +2.14%
    SGRY annual cash flow from operations is up +2.14% year-on-year

    Cash from investing

    -$488.50M
    SGRY annual cash flow from investing activities is -$488.50 million

    Cash from investing 1-year change

    -116.53%
    SGRY annual cash flow from investing activities is down -116.53% year-on-year

    Cash from financing

    $262.00M
    SGRY annual cash flow from financing activities is $262.00 million

    Cash from financing 1-year change

    +268.81%
    SGRY annual cash flow from financing activities is up +268.81% year-on-year

    CAPEX

    CAPEX

    $90.40M
    SGRY annual capital expenditures is $90.40 million

    CAPEX 1-year change

    +1.8%
    SGRY annual capital expenditures is up +1.8% year-on-year

    Free Cash Flow

    Free cash flow

    $209.70M
    SGRY annual free cash flow is $209.70 million

    Free cash flow 1-year change

    +2.29%
    SGRY annual free cash flow is up +2.29% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    23.94%
    SGRY annual gross profit margin is 23.94%

    Operating margin

    14.59%
    SGRY annual operating profit margin is 14.59%

    Net margin

    -5.40%
    SGRY annual net profit margin is -5.40%

    ROA & ROE

    ROA

    -2.28%
    SGRY annual return on assets is -2.28%

    ROE

    -4.80%
    SGRY annual return on equity is -4.80%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    SGRY price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    SGRY price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.57
    SGRY price to book ratio is 1.57

    PB ratio Sector rank

    47.73%
    SGRY price to book ratio is higher than 47.73% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.86
    SGRY price to sales ratio is 0.86

    PS ratio Sector rank

    21.2%
    SGRY price to sales ratio is higher than 21.2% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $6.36B
    SGRY enterprise value is $6.36 billion

    Enterprise value Sector rank

    89.41%
    SGRY enterprise value is higher than 89.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    12.98
    SGRY EV/EBITDA is 12.98

    EV/EBITDA Sector rank

    86.44%
    SGRY EV/EBITDA is higher than 86.44% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.79
    SGRY annual current ratio is 1.79

    Quick ratio

    1.65
    SGRY annual quick ratio is 1.65

    Leverage

    Debt to equity

    1.88
    SGRY annual debt to equity ratio is 1.88

    Interest coverage ratio

    1.73
    SGRY annual interest coverage ratio is 1.73

    Risk & Stability

    Piotroski F-Score

    3
    SGRY piotroski f-score is 3

    Altman Z-Score

    0.87
    SGRY altman z-score is 0.87

    Analyst ratings

    Recent major analysts updates

    May 27, 25 Barclays
    Equal-Weight
    Apr 21, 25 Benchmark
    Buy
    Mar 25, 25 RBC Capital
    Outperform
    Mar 11, 25 Macquarie
    Outperform
    Dec 3, 24 JP Morgan
    Neutral
    Nov 20, 24 RBC Capital
    Outperform
    Nov 19, 24 Macquarie
    Outperform
    Nov 13, 24 Macquarie
    Outperform
    Nov 4, 24 Macquarie
    Outperform
    Oct 14, 24 UBS
    Buy

    Institutional Ownership

    Screeners with SGRY included

    Growing Shares Outstanding
    Mid cap stocks
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Surgery Partners, Inc.?
    • Does Surgery Partners, Inc. pay dividends?
    • What sector is Surgery Partners, Inc. in?
    • What industry is Surgery Partners, Inc. in?
    • What country is Surgery Partners, Inc. based in?
    • When did Surgery Partners, Inc. go public?
    • Is Surgery Partners, Inc. in the S&P 500?
    • Is Surgery Partners, Inc. in the NASDAQ 100?
    • Is Surgery Partners, Inc. in the Dow Jones?
    • When was Surgery Partners, Inc.'s last earnings report?
    • When does Surgery Partners, Inc. report earnings?

    What is the ticker symbol for Surgery Partners, Inc.?

    The ticker symbol for Surgery Partners, Inc. is NASDAQ:SGRY

    Does Surgery Partners, Inc. pay dividends?

    No, Surgery Partners, Inc. does not pay dividends

    What sector is Surgery Partners, Inc. in?

    Surgery Partners, Inc. is in the Healthcare sector

    What industry is Surgery Partners, Inc. in?

    Surgery Partners, Inc. is in the Medical Care Facilities industry

    What country is Surgery Partners, Inc. based in?

    Surgery Partners, Inc. is headquartered in United States

    When did Surgery Partners, Inc. go public?

    Surgery Partners, Inc.'s initial public offering (IPO) was on September 30, 2015

    Is Surgery Partners, Inc. in the S&P 500?

    No, Surgery Partners, Inc. is not included in the S&P 500 index

    Is Surgery Partners, Inc. in the NASDAQ 100?

    No, Surgery Partners, Inc. is not included in the NASDAQ 100 index

    Is Surgery Partners, Inc. in the Dow Jones?

    No, Surgery Partners, Inc. is not included in the Dow Jones index

    When was Surgery Partners, Inc.'s last earnings report?

    Surgery Partners, Inc.'s most recent earnings report was on May 12, 2025

    When does Surgery Partners, Inc. report earnings?

    The next expected earnings date for Surgery Partners, Inc. is August 5, 2025
    On this page